Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, Pringsheim T, Lorenzetti DL, Jetté N (2017) Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology 88(3):296–303. https://doi.org/10.1212/wnl.0000000000003509

Article  PubMed  PubMed Central  Google Scholar 

Singh G, Sander JW (2020) The global burden of epilepsy report: Implications for low-and middle-income countries. Epilepsy Behav 105:106949. https://doi.org/10.1016/j.yebeh.2020.106949

Article  PubMed  Google Scholar 

Engelborghs S, D’hooge R, De Deyn P (2000) Pathophysiology of epilepsy. Acta Neurol Belg 100(4):201–213. (https://www.ncbi.nlm.nih.gov/pubmed/11233674)

CAS  PubMed  Google Scholar 

SB Andavan G, Lemmens-Gruber R (2011) Voltage-gated sodium channels: mutations, channelopathies and targets. Curr Med Chem 18(3):377–397. https://doi.org/10.2174/092986711794839133

Article  Google Scholar 

Wallace R, Scheffer I, Barnett S, Richards M, Dibbens L, Desai R, Lerman-Sagie T, Lev D, Mazarib A, Brand N (2001) Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J of Hum Genet 68(4):859–865. https://doi.org/10.1086/319516

Article  CAS  Google Scholar 

Escayg A, Heils A, MacDonald BT, Haug K, Sander T, Meisler MH (2001) A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus—and prevalence of variants in patients with epilepsy. Am J of Hum Genet 68(4):866–873. https://doi.org/10.1086/319524

Article  CAS  Google Scholar 

Lossin C (2009) A catalog of SCN1A variants. Brain Dev 31(2):114–130. https://doi.org/10.1016/j.braindev.2008.07.011

Article  PubMed  Google Scholar 

Meisler MH, Kearney JA (2005) Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 115(8):2010–2017. https://doi.org/10.1172/JCI25466

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schlachter K, Gruber-Sedlmayr U, Stogmann E, Lausecker M, Hotzy C, Balzar J, Schuh E, Baumgartner C, Mueller JC, Illig T (2009) A splice site variant in the sodium channel gene SCN1A confers risk of febrile seizures. Neurology 72(11):974–978. https://doi.org/10.1212/01.wnl.0000344401.02915.00

Article  CAS  PubMed  Google Scholar 

Weale ME, Depondt C, Macdonald SJ, Smith A, San Lai P, Shorvon SD, Wood NW, Goldstein DB (2003) Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J of Hum Genet 73(3):551–565. https://doi.org/10.1086/378098

Article  CAS  Google Scholar 

Chapman SC, Horne R, Chater A, Hukins D, Smithson WH (2014) Patients’ perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav 31:312–320. https://doi.org/10.1016/j.yebeh.2013.10.016

Article  CAS  PubMed  Google Scholar 

Xie X, Dale TJ, John VH, Cater HL, Peakman TC, Clare JJ (2001) Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line. Pflugers Arch 441(4):425–433. https://doi.org/10.1007/s004240000448

Article  CAS  PubMed  Google Scholar 

Rogawski MA, Löscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5(7):553–564. https://doi.org/10.1038/nrn1430

Article  CAS  PubMed  Google Scholar 

Wang P, Zhou Q, Sheng Y, Tang B, Liu Z, Zhou B (2014) Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients. Zhong nan da xue xue bao. Yi xue ban 39(5):433–441. https://doi.org/10.3969/j.issn.1672-7347.2014.05.001

Article  CAS  PubMed  Google Scholar 

Löscher W, Potschka H (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301(1):7–14. https://doi.org/10.1124/jpet.301.1.7

Article  PubMed  Google Scholar 

Li M, Zhong R, Lu Y, Zhao Q, Li G, Lin W (2020) Association between SCN1A rs2298771, SCN1A rs10188577, SCN2A rs17183814, and SCN2A rs2304016 Polymorphisms and responsiveness to antiepileptic drugs: a meta-analysis. Front Neurol 11:591828. https://doi.org/10.3389/fneur.2020.591828

Article  PubMed  Google Scholar 

Bao Y, Liu X, Xiao Z (2018) Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis. Neurol Sci 39(6):1065–1072. https://doi.org/10.1007/s10072-018-3308-3

Article  PubMed  Google Scholar 

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069–1077. https://doi.org/10.1111/j.1528-1167.2009.02397.x

Article  CAS  PubMed  Google Scholar 

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 9 Nov 2024

Borenstein M (2022) Comprehensive meta‐analysis software. Systematic reviews in health research: meta‐analysis in context, pp 535–548

Chochrane Handbook, Chapter 9.5.2 : Identifying and measuring heterogeneity. https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm Accessed 9 Nov 2024

Shi L, Zhu M, Li H, Wen Z, Chen X, Luo J, Lin C, Zhang Z (2019) SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients. Eur J Clin Pharmacol 75(5):655–663. https://doi.org/10.1007/s00228-019-02633-0

Article  CAS  PubMed  Google Scholar 

Haddaway NR, Page MJ, Pritchard CC, McGuinness LA (2022) PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev 18(2):e1230. https://doi.org/10.1002/cl2.1230

Article  PubMed  PubMed Central  Google Scholar 

Abduljabbar R et al (2023) SCN1A polymorphisms influence the antiepileptic drugs responsiveness in Jordanian epileptic patients. J Med Biochem 42(2):214–223

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abe T et al (2008) Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Br J Clin Pharmacol 66(2):304–307

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abo El Fotoh WM et al (2016) The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children. Seizure 41:75–80

Article  PubMed  Google Scholar 

Alghamdi MA et al (2022) Association of sodium voltage-gated channel genes polymorphisms with epilepsy risk and prognosis in the Saudi population. Ann Med 54(1):1938–1951

Article  CAS  PubMed  PubMed Central  Google Scholar 

Angelopoulou C et al (2017) Association of SCN1A gene polymorphism with antiepileptic drug responsiveness in the population of Thrace, Greece. Arch Med Sci 13(1):138–147

Article  CAS  PubMed  Google Scholar 

Ashfaq A et al (2022) Genetic analysis of sodium channel genes in pediatric epilepsy patients of Pakistan. Genet Res (Camb) 2022:1168703

Article  PubMed  Google Scholar 

Baghel R et al (2016) Evaluating the role of genetic variants on first-line antiepileptic drug response in North India: significance of SCN1A and GABRA1 Gene variants in phenytoin monotherapy and its serum drug levels. CNS Neurosci Ther 22(9):740–757

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balan S et al (2012) Failure to find association between febrile seizures and SCN1A rs3812718 polymorphism in south Indian patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Epilepsy Res 101(3):288–292

Article  CAS  PubMed  Google Scholar 

Bao Z et al (2024) Effect of SCN1Aand SCN2A gene polymorphisms on the efficacy of valproic acid treatment in Chinese children with epilepsy. PLoS ONE 19(6):e0304869

Article